Literature DB >> 33838229

Olive oil-derived nitro-fatty acids: protection of mitochondrial function in non-alcoholic fatty liver disease.

Beatriz Sánchez-Calvo1, Adriana Cassina2, Mauricio Mastrogiovanni2, Mariela Santos3, Emiliano Trias4, Eric E Kelley5, Homero Rubbo2, Andrés Trostchansky6.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive liver fat deposition in the absence of significant alcohol intake. Since extra virgin olive oil (EVOO) reduces fat accumulation, we analyzed the involvement of nitro-fatty acids (NO2-FA) on the beneficial effects of EVOO consumption on NAFLD. Nitro-fatty acids formation was observed during digestion in mice supplemented with EVOO and nitrite. Mice fed with a high-fat diet (HF) presented lower plasma NO2-FA levels than normal chow, and circulating concentrations recovered when the HF diet was supplemented with 10% EVOO plus nitrite. Under NO2-FA formation conditions, liver hemoxygenase-1 expression significantly increased while decreased body weight and fat liver accumulation. Mitochondrial dysfunction plays a central role in the pathogenesis of NAFLD while NO2-FA has been shown to protect from mitochondrial oxidative damage. Accordingly, an improvement of respiratory indexes was observed when mice were supplemented with both EVOO plus nitrite. Liver mitochondrial complexes II and V activities were greater in mice with EVOO supplementation and further improved in the presence of nitrite. Overall, our results strongly suggest a positive correlation between NO2-OA formation from EVOO and the observed improvement of mitochondrial function in NAFLD. The formation of NO2-FA can account for the health benefits associated with EVOO consumption.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Cell signaling; High fat diet; Mediterranean diet; Mitochondria; Nitroalkenes; Non-alcoholic fatty liver disease; Nutrition Liver

Mesh:

Substances:

Year:  2021        PMID: 33838229      PMCID: PMC8197755          DOI: 10.1016/j.jnutbio.2021.108646

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.117


  88 in total

1.  Partial resolution of the enzymes catalyzing oxidative phosphorylation. I. Purification and properties of soluble dinitrophenol-stimulated adenosine triphosphatase.

Authors:  M E PULLMAN; H S PENEFSKY; A DATTA; E RACKER
Journal:  J Biol Chem       Date:  1960-11       Impact factor: 5.157

Review 2.  Formation and signaling actions of electrophilic lipids.

Authors:  Francisco J Schopfer; Chiara Cipollina; Bruce A Freeman
Journal:  Chem Rev       Date:  2011-09-20       Impact factor: 60.622

3.  Moderate consumption of olive oil by healthy European men reduces systolic blood pressure in non-Mediterranean participants.

Authors:  Isabel Bondia-Pons; Helmut Schröder; María-Isabel Covas; Ana I Castellote; Jari Kaikkonen; Henrik E Poulsen; Antonio V Gaddi; Anja Machowetz; Holger Kiesewetter; M Carmen López-Sabater
Journal:  J Nutr       Date:  2007-01       Impact factor: 4.798

4.  Nitro-oleic acid inhibits angiotensin II-induced hypertension.

Authors:  Jifeng Zhang; Luis Villacorta; Lin Chang; Zhenzhen Fan; Milton Hamblin; Tianqing Zhu; Chen S Chen; Marsha P Cole; Francisco J Schopfer; Cheri X Deng; Minerva T Garcia-Barrio; Ying-Hong Feng; Bruce A Freeman; Y Eugene Chen
Journal:  Circ Res       Date:  2010-06-17       Impact factor: 17.367

5.  Detection and quantification of protein adduction by electrophilic fatty acids: mitochondrial generation of fatty acid nitroalkene derivatives.

Authors:  F J Schopfer; C Batthyany; P R S Baker; G Bonacci; M P Cole; V Rudolph; A L Groeger; T K Rudolph; S Nadtochiy; P S Brookes; B A Freeman
Journal:  Free Radic Biol Med       Date:  2009-05-01       Impact factor: 7.376

6.  Nitro-fatty acids occur in human plasma in the picomolar range: a targeted nitro-lipidomics GC-MS/MS study.

Authors:  Dimitrios Tsikas; Alexander A Zoerner; Anja Mitschke; Frank-Mathias Gutzki
Journal:  Lipids       Date:  2009-08-22       Impact factor: 1.880

7.  Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice.

Authors:  E A Kirk; P Sutherland; S A Wang; A Chait; R C LeBoeuf
Journal:  J Nutr       Date:  1998-06       Impact factor: 4.798

Review 8.  Effects of Olive Oil and Its Minor Components on Cardiovascular Diseases, Inflammation, and Gut Microbiota.

Authors:  Gabriela Marcelino; Priscila Aiko Hiane; Karine de Cássia Freitas; Lidiani Figueiredo Santana; Arnildo Pott; Juliana Rodrigues Donadon; Rita de Cássia Avellaneda Guimarães
Journal:  Nutrients       Date:  2019-08-07       Impact factor: 5.717

9.  Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).

Authors:  Ritu S Sharma; David J Harrison; Dorothy Kisielewski; Diane M Cassidy; Alison D McNeilly; Jennifer R Gallagher; Shaun V Walsh; Tadashi Honda; Rory J McCrimmon; Albena T Dinkova-Kostova; Michael L J Ashford; John F Dillon; John D Hayes
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-12-13

Review 10.  Nitrates/Nitrites in Food-Risk for Nitrosative Stress and Benefits.

Authors:  Małgorzata Karwowska; Anna Kononiuk
Journal:  Antioxidants (Basel)       Date:  2020-03-16
View more
  2 in total

Review 1.  Therapeutic Properties and Use of Extra Virgin Olive Oil in Clinical Nutrition: A Narrative Review and Literature Update.

Authors:  Andrés Jiménez-Sánchez; Antonio Jesús Martínez-Ortega; Pablo Jesús Remón-Ruiz; Ana Piñar-Gutiérrez; José Luis Pereira-Cunill; Pedro Pablo García-Luna
Journal:  Nutrients       Date:  2022-03-31       Impact factor: 5.717

Review 2.  The Potential of the Mediterranean Diet to Improve Mitochondrial Function in Experimental Models of Obesity and Metabolic Syndrome.

Authors:  Mohamad Khalil; Harshitha Shanmugam; Hala Abdallah; Jerlin Stephy John Britto; Ilaria Galerati; Javier Gómez-Ambrosi; Gema Frühbeck; Piero Portincasa
Journal:  Nutrients       Date:  2022-07-28       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.